Evaluation of changes in neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with vitiligo
Yıl: 2019 Cilt: 26 Sayı: 7 Sayfa Aralığı: 1344 - 1346 Metin Dili: İngilizce DOI: 10.5455/annalsmedres.2019.03.152 İndeks Tarihi: 07-01-2020
Evaluation of changes in neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with vitiligo
Öz: Aim: Vitiligo is an acquired disease with loss of melanocytes, etiology of which is unclear. The aim of this study is to determinethe role of systemic inflammation in vitiligo by measuring the Neutrophil-Lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR)markers included in routine hemogram test, in patients with vitiligo.Material and Methods: The study was carried out by reviewing the data of patients who applied to İnönü University Faculty ofMedicine Dermatology Polyclinic and diagnosed with vitiligo after Wood’s lamp examination, between July 2012 and February 2018.The study was performed retrospectively by reviewing patient files and ethics committee approval was not obtained.Results: A total of 170 individuals including 79 vitiligo patients and 91 healthy individuals were included in the study. When the vitiligopatients and healthy control group were compared in terms of routine hemogram parameters, statistically significant differenceswere found in terms of erythrocyte distribution width (RDW), but there were no statistically significant differences in terms of NLR,PLR, lymphocyte, neutrophil, platelets and White bloodcell (WBC) counts.Conclusion: In our study, only RDW value was found to be higher in patients with vitiligo compared to healthy controls, and nodifference was found in other parameters indicating systemic inflammation.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Lotti T, Gianfaldoni S, Valle Y, et al. Controversial issues in vitiligo patients: a review of old and recent treatments. Dermatol Ther 2018;17:12745.
- 2. Ghorbanibirgani A, Khalili A, Rokhafrooz D. Comparing nigella sativa oil and fish oil in treatment of vitiligo. Iran Red Crescent Med J 2014;16:4515.
- 3. Mohammed GF, Gomaa AH, Al-Dhubaibi MS. Highlights in pathogenesis of vitiligo. World J Clin Cases 2015;16:221-30.
- 4. Balkarli A, Kucuk A, Babur H, et al. Neutrophil/lymphocyte ratio and mean platelet volume in Behcet’s disease. Eur Med Pharmacol Sci 2016;20:3045-50.
- 5. Ma J, Kuzman J, Ray A, et al. Neutrophil-to-lymphocyte Ratio (NLR) as a predictor for recurrence in patients with stage III melanoma. Sci Rep 2018;8:4044.
- 6. Ahsen A, Ulu MS, Yuksel S, et al. As a new inflammatory marker for familial Mediterranean fever: neutrophil-tolymphocyte ratio. Inflammation 2013;36:1357-62.
- 7. Ünal M, Küçük A, Ünal GÜ, et al. Psoriasiste ortalama trombosit hacmi, nötrofil/lenfosit oranı ve trombosit/ lenfosit oranı. Türkderm 2015;49:112-6.
- 8. Cemil BÇ, Ataş H. The Effect of Biological Treatment onto Systemic Inflammatory Markers and Plateletcrit in Psoriasis Patients. Dicle Tıp Dergisi, Dicle Med J 2016;43:477-83.
- 9. G Sarac, İ Mantar, S Sener, et al. Assessment of change in neutrophil-lymphocyte ratio, platelet-lymphocyteratio in patients with acute and chronic urticaria. Ann Med Res 2018;25:719-22.
- 10. ME Yanık, G Erfan, H Albayrak, et al. Alopesi areata hastalarinda nötrofil/lenfosit oraninin ve diğer inflamatuar parametrelerin normal popülasyon ile karşilaştirilmasi. Genel Tıp Derg 2016;26:46-9.
APA | Saraç G, ALTUNIŞIK N, ŞENER S, hakverdi g (2019). Evaluation of changes in neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with vitiligo. , 1344 - 1346. 10.5455/annalsmedres.2019.03.152 |
Chicago | Saraç Gülbahar,ALTUNIŞIK Nihal,ŞENER Serpil,hakverdi gülden Evaluation of changes in neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with vitiligo. (2019): 1344 - 1346. 10.5455/annalsmedres.2019.03.152 |
MLA | Saraç Gülbahar,ALTUNIŞIK Nihal,ŞENER Serpil,hakverdi gülden Evaluation of changes in neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with vitiligo. , 2019, ss.1344 - 1346. 10.5455/annalsmedres.2019.03.152 |
AMA | Saraç G,ALTUNIŞIK N,ŞENER S,hakverdi g Evaluation of changes in neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with vitiligo. . 2019; 1344 - 1346. 10.5455/annalsmedres.2019.03.152 |
Vancouver | Saraç G,ALTUNIŞIK N,ŞENER S,hakverdi g Evaluation of changes in neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with vitiligo. . 2019; 1344 - 1346. 10.5455/annalsmedres.2019.03.152 |
IEEE | Saraç G,ALTUNIŞIK N,ŞENER S,hakverdi g "Evaluation of changes in neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with vitiligo." , ss.1344 - 1346, 2019. 10.5455/annalsmedres.2019.03.152 |
ISNAD | Saraç, Gülbahar vd. "Evaluation of changes in neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with vitiligo". (2019), 1344-1346. https://doi.org/10.5455/annalsmedres.2019.03.152 |
APA | Saraç G, ALTUNIŞIK N, ŞENER S, hakverdi g (2019). Evaluation of changes in neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with vitiligo. Annals of Medical Research, 26(7), 1344 - 1346. 10.5455/annalsmedres.2019.03.152 |
Chicago | Saraç Gülbahar,ALTUNIŞIK Nihal,ŞENER Serpil,hakverdi gülden Evaluation of changes in neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with vitiligo. Annals of Medical Research 26, no.7 (2019): 1344 - 1346. 10.5455/annalsmedres.2019.03.152 |
MLA | Saraç Gülbahar,ALTUNIŞIK Nihal,ŞENER Serpil,hakverdi gülden Evaluation of changes in neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with vitiligo. Annals of Medical Research, vol.26, no.7, 2019, ss.1344 - 1346. 10.5455/annalsmedres.2019.03.152 |
AMA | Saraç G,ALTUNIŞIK N,ŞENER S,hakverdi g Evaluation of changes in neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with vitiligo. Annals of Medical Research. 2019; 26(7): 1344 - 1346. 10.5455/annalsmedres.2019.03.152 |
Vancouver | Saraç G,ALTUNIŞIK N,ŞENER S,hakverdi g Evaluation of changes in neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with vitiligo. Annals of Medical Research. 2019; 26(7): 1344 - 1346. 10.5455/annalsmedres.2019.03.152 |
IEEE | Saraç G,ALTUNIŞIK N,ŞENER S,hakverdi g "Evaluation of changes in neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with vitiligo." Annals of Medical Research, 26, ss.1344 - 1346, 2019. 10.5455/annalsmedres.2019.03.152 |
ISNAD | Saraç, Gülbahar vd. "Evaluation of changes in neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with vitiligo". Annals of Medical Research 26/7 (2019), 1344-1346. https://doi.org/10.5455/annalsmedres.2019.03.152 |